美股A股
StockGist
Back
10-K2026-03-18· deepseek-v4-flash

CORZZ · Core Scientific, Inc.

0001628280-26-019505

SEC filing

Summary

Core Scientific filed a 10-K/A amendment solely to attach Exhibit 97.1, with no changes to financial statements.

Key takeaways

Full analysis

Filing Overview

This Amendment No. 1 on Form 10-K/A was filed by Core Scientific, Inc. on March 18, 2026, to amend its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, originally filed on March 2, 2026. The sole purpose of this amendment is to attach Exhibit 97.1 (Policy on Recoupment of Incentive Compensation), which was inadvertently omitted from the original filing. The amendment explicitly states that no changes have been made to the financial or other information contained in the original filing, and it does not reflect events subsequent to the original filing date.

Period Performance

No financial performance data for the fiscal year 2025 or any prior period is included in this amendment. The original 10-K filing, which contains the full financial statements, MD&A, and other disclosures, is not provided in this document. Therefore, no analysis of revenue, profitability, or earnings per share can be derived from this amendment.

Balance Sheet & Liquidity

No balance sheet or liquidity information is included in this amendment. The only capitalization data available are the aggregate market value of common stock ($4.25 billion as of June 30, 2025) and the number of shares outstanding (315,332,655 as of February 26, 2026), both of which are from the cover page.

Cash Flow Quality

No cash flow information is provided in this amendment. The original filing's cash flow statements are not included.

MD&A / Forward View

No Management's Discussion and Analysis or forward-looking statements are contained in this amendment. The explanatory note clarifies that the amendment does not modify any disclosures.

Notes & Operating Detail

No operating notes, segment data, or additional financial details are present. The amendment is purely administrative, adding a single exhibit. The certifications under Section 302 of the Sarbanes-Oxley Act are included for the CEO and CFO, but they relate only to the amendment's content.

Investor Implications

This filing is routine and does not affect the company's financial standing or operational outlook. Investors should refer to the original 10-K for comprehensive financial information. The only metrics available are the market capitalization and share count, which indicate a publicly traded company with a significant float.